Antiviral drugs from basic discovery through clinical trials /
Furkejuvvon:
| Searvvušdahkki: | |
|---|---|
| Eará dahkkit: | |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Hoboken, N.J. :
Wiley,
c2011.
|
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- pt. 1. Human immunodeficiency virus. section 1. HIV protease inhibitors ; section 2. HIV non-nucleoside reverse transcriptase inhibitors ; section 3. HIV nucleoside reverse transcriptase inhibitors ; section 4. HIV entry inhibitors ; section 5. HIV integrase inhibitors
- pt. 2. Hepatitis C virus. section 6. Protease inhibitors ; section 7. HCV polymerase nucleoside inhibitors ; section 8. Other HCV inhibitors
- pt. 3. Respiratory syncytial virus inhibitors
- pt. 4. Influenza, Hepatitis B, and Cytomegalovirus inhibitors.